Cincinnati, OH, United States of America

Philippe Bey

This inventor holds 46 USPTO granted patents, plus 6 CIPO patents, primarily in Peptidase Inhibitors. Top assignees: Merrell Dow Pharmaceuticals, Merrell Toraude Et Compagnie, Merrell Dow France Et Cie.. Active years: 1979-1998.


% Patents Active = 100.0

 

Average Co-Inventor Count = 2.5

ph-index = 17

Forward Citations = 828(Granted Patents)


Location History:

  • Strasbourg, FR (1979 - 1997)
  • Cincinnati, OH (US) (1985 - 1998)

Company Filing History:


Years Active: 1979-1998

Loading Chart...
Loading Chart...
Areas of Expertise:
Peptidase Inhibitors
Tumor Growth Control
Lysyl Oxidase
Enkephalinase Inhibitors
Mercaptoacetylamide Derivatives
Cyclopropyl Squalene
Fluorinated Amino Acids
MAO Inhibitors
Parkinson's Treatment
Psoriasis Treatment
Connective Tissue
Protozoal Growth Inhibition
46 patents (USPTO):Explore Patents

Title: The Inventor Extraordinaire: Philippe Bey

Introduction:

Philippe Bey, a prolific inventor based in Cincinnati, OH, is known for his remarkable contributions to the field of medicine through his innovative patents. With a total of 46 patents to his name, Bey's work has significantly impacted the healthcare industry.

Latest Patents:

One of Philippe Bey's latest patents includes the development of Peptidase Inhibitors. These analogs of peptidase substrates offer specific enzyme inhibitors for various proteases, with potential applications in treating diverse disease states. Additionally, Bey's invention of a Method of Controlling Tumor Growth Rate involving .alpha.-Fluoromethyl- or .alpha.-difluoromethylornithine showcases his dedication to advancing cancer treatment solutions.

Career Highlights:

Throughout his career, Philippe Bey has held key positions at renowned companies such as Merrell Dow Pharmaceuticals and Merrell Toraude et Compagnie. His experience in these prestigious organizations has undoubtedly shaped his innovative thinking and scientific prowess.

Collaborations:

Bey has had the privilege of collaborating with esteemed professionals in the industry, including his coworkers Michel Jung and Michael G. Palfreyman. These collaborations have fostered a dynamic exchange of ideas and expertise, leading to groundbreaking innovations in the field of medicine.

Conclusion:

In conclusion, Philippe Bey stands as a beacon of innovation in the realm of healthcare inventions. His dedication to developing novel solutions for complex medical challenges has garnered him well-deserved recognition within the scientific community. Philippe Bey's inventive spirit continues to inspire future generations of inventors to push the boundaries of what is possible in the pursuit of enhancing human health and well-being.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…